Technical Analysis for NEOS - Neos Therapeutics, Inc.

Grade Last Price % Change Price Change
B 1.15 -2.54% -0.03
NEOS closed down 2.54 percent on Friday, March 19, 2021, on 1.94 times normal volume.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Up
Historical NEOS trend table...

Date Alert Name Type % Chg
180 Bullish Setup Bullish Swing Setup 0.00%
Calm After Storm Range Contraction 0.00%
Upper Bollinger Band Walk Strength 0.00%
Wide Bands Range Expansion 0.00%
Pocket Pivot Bullish Swing Setup -2.54%
Volume Surge Other -2.54%
Wide Range Bar Range Expansion -2.54%
New 52 Week High Strength -2.54%
Wide Bands Range Expansion -2.54%
Above Upper BB Strength -2.54%
Older End-of-Day Signals for NEOS ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
No Alerts Yet. Alerts will only show here if at least one person is tracking alerts on this stock.
View Earlier Intraday Alerts

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Neos Therapeutics, Inc. Description

Neos Therapeutics, Inc., a pharmaceutical company, develops, manufactures, and commercializes products for the treatment of attention deficit hyperactivity disorder (ADHD) using its drug delivery technologies. Its product candidates are extended-release (XR) medications in orally disintegrating tablets or liquid suspension dosage forms. The company manufactures and markets generic Tussionex, a hydrocodone polistirex and chlorpheniramine polistirex XR liquid suspension product indicated for the relief of cough and upper respiratory symptoms associated with allergies or colds in adults and children of six years of age and older. Its product candidates include NT-0102 methylphenidate XR orally disintegrating tablet for the treatment of ADHD; NT-0202 amphetamine XR orally disintegrating tablet for the treatment of ADHD; and NT-0201 amphetamine XR liquid suspension for the treatment of ADHD. The company is headquartered in Grand Prairie, Texas.


Classification

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Keywords: Pharmaceutical Drugs Pharmacology Symptoms Drug Delivery Psychoactive Drugs Euphoriants Dosage Forms Suspension Attention Deficit Attention Deficit Hyperactivity Disorder Cough Hyperactivity Disorder Amphetamine Allergies Hydrocodone Adhd Methylphenidate Neos Treatment Of Attention Deficit Hyperactivity Disorder Delivery Technologies Drug Delivery Technologies Stimulants Nootropics Phenethylamines

Is NEOS a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 1.68
52 Week Low 0.4501
Average Volume 7,484,269
200-Day Moving Average 0.73
50-Day Moving Average 0.91
20-Day Moving Average 0.93
10-Day Moving Average 1.00
Average True Range 0.14
ADX 29.95
+DI 49.35
-DI 16.74
Chandelier Exit (Long, 3 ATRs ) 1.26
Chandelier Exit (Short, 3 ATRs ) 1.09
Upper Bollinger Band 1.19
Lower Bollinger Band 0.68
Percent B (%b) 0.93
BandWidth 54.07
MACD Line 0.06
MACD Signal Line 0.02
MACD Histogram 0.0337
Fundamentals Value
Market Cap 57.22 Million
Num Shares 49.8 Million
EPS -0.78
Price-to-Earnings (P/E) Ratio -1.47
Price-to-Sales 0.57
Price-to-Book 0.00
PEG Ratio -0.02
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.33
Resistance 3 (R3) 1.32 1.25 1.30
Resistance 2 (R2) 1.25 1.20 1.25 1.29
Resistance 1 (R1) 1.20 1.18 1.16 1.21 1.28
Pivot Point 1.13 1.13 1.11 1.13 1.13
Support 1 (S1) 1.08 1.08 1.05 1.09 1.02
Support 2 (S2) 1.01 1.06 1.02 1.01
Support 3 (S3) 0.96 1.01 1.00
Support 4 (S4) 0.97